Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening

NCT06472869 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06472869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 23, 2024
Completion date
December 30, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electronic cigarette use, nicotine dependence, smoking, cigarette